Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making

被引:8
作者
Sola-Morales, Oriol [1 ]
Siguroardottir, Katla [1 ]
Akehurst, Ron [2 ]
Murphy, Linda A. [2 ]
Mestre-Ferrandiz, Jorge
Cunningham, David
de Pouvourville, Gerard [3 ]
机构
[1] Fdn HiTT, Barcelona, Spain
[2] Lumanity Inc, Sheffield, England
[3] ESSEC Business Sch, Cergy Pontoise, France
关键词
data governance; real-world data; real-world evidence; BIG DATA; TASK-FORCE; HEALTH;
D O I
10.1016/j.jval.2023.02.012
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Real-world data (RWD) and real-world evidence (RWE) can provide extensive information on healthcare for use in health technology assessment and decision making. Nevertheless, there is a lack of consensus surrounding the appropriate data governance (DG) practices for RWD/RWE. Data sharing is also a large concern, especially considering evolving data protection regulations. Our objective is to propose recommendations for international standards of evaluating the acceptability of RWD governance practices. Methods: After reviewing the literature, we created a checklist targeting DG practices for RWD/RWE. We then carried out a 3-round Delphi panel, including European policy makers, health technology assessment experts, and hospital managers. The consensus for each statement was measured and the checklist adjusted accordingly. Results: The literature review identified the main topics regarding RWD/RWE DG practices: data privacy and security, data management and linkage, data access management, and the generation and use of RWE. Members of the Delphi panel (21 experts/25 invited) were presented a total of 24 statements related to each of the topics. Experts demonstrated a progressive level of consensus and importance ratings in all topics and to most statements. We suggest a refined checklist in which the statements rated less important or with less consensus have been removed. Conclusions: This study suggests how the DG of RWD/RWE could be qualitatively evaluated. We propose checklists that could be used by all RWD/RWE users to help ensure the quality and integrity of RWD/RWE governance and complement data protection law.
引用
收藏
页码:32 / 42
页数:11
相关论文
共 50 条
  • [21] Real-world data in Saudi Arabia: Current situation and challenges for regulatory decision-making
    Alnofal, Fatemah A.
    Alrwisan, Adel A.
    Alshammari, Thamir M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1303 - 1306
  • [22] Landscape review of global real-world data sources for studying medication use in pregnancy and lactation that support regulatory decision making
    Davis, Kourtney
    Yost, Emily
    Brauneis, Jacquelyne
    Krumme, Alexis
    Geldhof, Anja
    Tuck, Astrud
    Sylvester, Shirley
    Ephross, Sara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [23] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [24] Impact of Real-World Data on Market Authorization, Reimbursement Decision & Price Negotiation
    Alfredo Aram Pulini
    Gabriela Martins Caetano
    Henri Clautiaux
    Laure Vergeron
    Peter J. Pitts
    Gregory Katz
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 228 - 238
  • [25] A national evaluation analysis and expert interview study of real-world data sources for research and healthcare decision-making
    Mikl, Veronika
    Baltic, Dejan
    Czypionka, Thomas
    Degelsegger-Marquez, Alexander
    Forgo, Nikolaus
    Gouya-Lechner, Ghazaleh
    Herzog, Arnold
    Klimek, Peter
    Lumenta, David Benjamin
    Mraz, Bernhard
    Ostermann, Herwig
    Scharinger, Robert
    Stamm, Tanja
    Strassnig, Michael
    Zeitlinger, Markus
    Pleiner-Duxneuner, Johannes
    SCIENTIFIC REPORTS, 2024, 14 (01): : 9751
  • [26] Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus
    Klimek, Peter
    Baltic, Dejan
    Brunner, Martin
    Degelsegger-Marquez, Alexander
    Garhoefer, Gerhard
    Gouya-Lechner, Ghazaleh
    Herzog, Arnold
    Jilma, Bernd
    Kaehler, Stefan
    Mikl, Veronika
    Mraz, Bernhard
    Ostermann, Herwig
    Roehl, Claas
    Scharinger, Robert
    Stamm, Tanja
    Strassnig, Michael
    Wirthumer-Hoche, Christa
    Pleiner-Duxneuner, Johannes
    JMIR MEDICAL INFORMATICS, 2022, 10 (06)
  • [27] Use of real-world evidence for oncology clinical decision making in emerging economies
    Petracci, Fernando
    Ghai, Chirag
    Pangilinan, Andrew
    Suarez, Luis Alberto
    Uehara, Roberto
    Ghosn, Marwan
    FUTURE ONCOLOGY, 2021, 17 (22) : 2951 - 2960
  • [28] Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet
    Hoffmann, Mikael
    Vander Stichele, Robert
    Bates, David W.
    Bjorklund, Johanna
    Alexander, Steve
    Andersson, Marine L.
    Auraaen, Ane
    Bennie, Marion
    Dahl, Marja-Liisa
    Eiermann, Birgit
    Hackl, Werner
    Hammar, Tora
    Hjemdahl, Paul
    Koch, Sabine
    Kunnamo, Ilkka
    Le Louet, Herve
    Panagiotis, Papapetrou
    Raego, Lembit
    Spedding, Michael
    Seidling, Hanna M.
    Demner-Fushman, Dina
    Gustafsson, Lars L.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (09) : 925 - 934
  • [29] Trusted Decision-Making: Data Governance for Creating Trust in Data Science Decision Outcomes
    Brous, Paul
    Janssen, Marijn
    ADMINISTRATIVE SCIENCES, 2020, 10 (04)
  • [30] Transferability of real-world data across borders for regulatory and health technology assessment decision-making
    Jaksa, Ashley
    Arena, Patrick J.
    Chan, Kelvin K. W.
    Ben-Joseph, Rami H.
    Jonsson, Pall
    Campbell, Ulka B.
    FRONTIERS IN MEDICINE, 2022, 9